Fact CheckerSign in

NCT04368702Recruiting

CONFIRM: Magnetic Resonance Guided Radiation Therapy

Clinical Onboard Utilization of Image Guided Radiation Therapy With Magnetic Resonance (CONFIRM): A Master Protocol

Source: ClinicalTrials.gov · Last updated 9 Feb 2026

Brief summary (registry, in English)

This research is being done to determine the safety and feasibility of using a type of radiation guided by magnetic resonance imaging (MRI) and chemotherapy to treat patients with gastric and breast cancer. The name of the radiation machine involved in this study is the MRIdian Linear Accelerator.

Status (registry)
Recruiting
Study type
Interventional
Enrollment
70 (estimated)
First submitted
22 Apr 2020
Start date
1 May 2021
Primary completion date
18 Jun 2029
Lead sponsor
Brigham and Women's Hospital
NCT number
NCT04368702

What you commit to

  • Study type: Interventional
  • Planned participants: 70
  • From 1 May 2021 to the primary completion date, 18 Jun 2029
  • 2 sites in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other illness

  • History of allergic reactions attributed to gadolinium-based IV contrast
    • \-- Note: If patient will not receive contrast, this is not applicable and kidney function will not affect eligibility
  • Any other exclusion criteria listed in the specific disease site cohort

Other

  • Severe claustrophobia or anxiety
  • Participants who cannot undergo an MRI

Who the study is looking for

  • Participants must have histologically or cytologically confirmed malignancy requiring radiation
  • Age 18 years of older
  • ECOG performance status ≤2 (Karnofsky ≥60%, see Appendix A)
  • Ability to understand and the willingness to sign a written informed consent document.
  • Any further criteria listed in the specific disease site cohort

Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (2)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Dana-Farber Cancer Institute
Coordinator of this site? Confirm its status
BostonUnited StatesRecruiting
Brigham & Women's Hospital
Coordinator of this site? Confirm its status
BostonUnited StatesRecruiting

This page is information, not medical advice. Discuss any trial with your doctor.